Exclusion criteria comprised a history of previous bariatric surgery, contraindications to IGB insertion or semaglutide use, the presence of gastrointestinal disorders such as inflammatory bowel disease or gastroparesis, severe organ dysfunction (renal, hepatic, or cardiac), pregnancy, and current use of other anti-obesity medications
[DOI] [PMC free article] [PubMed] [Google Scholar] 58.Implications of GLP-1 receptor agonist on thyroid function: a literature review of Its effects on thyroid volume, risk of cancer, functionality and TSH levels
doi: 10.1038/s41575-019-0247-2 18 BolVBolABouzinCLabarDLeeJAJanssensGet al
doi: 10.1016/j.coph.2016.08.005 110 GraafCDonnellyDWoottenDLauJSextonPMMillerLJet al
Peptides Sublingual GHK-Cu vs Injectable GHK-Cu: Which Is More Effective